Ghent University Academic Bibliography

Advanced

Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study

A DEMOLS, Marc Peeters UGent, M POLUS, R MARECHAL, F GAY, ELS MONSAERT, A HENDLISZ and JL VAN LAETHEM (2006) BRITISH JOURNAL OF CANCER. 94(4). p.481-485
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle
publication status
published
subject
journal title
BRITISH JOURNAL OF CANCER
Br. J. Cancer
volume
94
issue
4
pages
481-485 pages
publisher
NATURE PUBLISHING GROUP
Web of Science type
Article
Web of Science id
000235475300006
JCR category
ONCOLOGY
JCR impact factor
4.459 (2006)
JCR rank
33/125 (2006)
JCR quartile
2 (2006)
ISSN
0007-0920
language
English
UGent publication?
yes
classification
A1
id
332016
handle
http://hdl.handle.net/1854/LU-332016
date created
2006-04-20 09:17:00
date last changed
2008-02-22 22:58:24
@article{332016,
  author       = {DEMOLS, A and Peeters, Marc and POLUS, M and MARECHAL, R and GAY, F and MONSAERT, ELS and HENDLISZ, A and VAN LAETHEM, JL},
  issn         = {0007-0920},
  journal      = {BRITISH JOURNAL OF CANCER},
  language     = {eng},
  number       = {4},
  pages        = {481--485},
  publisher    = {NATURE PUBLISHING GROUP},
  title        = {Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study},
  volume       = {94},
  year         = {2006},
}

Chicago
DEMOLS, A, Marc Peeters, M POLUS, R MARECHAL, F GAY, ELS MONSAERT, A HENDLISZ, and JL VAN LAETHEM. 2006. “Gemcitabine and Oxaliplatin (GEMOX) in Gemcitabine Refractory Advanced Pancreatic Adenocarcinoma: a Phase II Study.” British Journal of Cancer 94 (4): 481–485.
APA
DEMOLS, A., Peeters, M., POLUS, M., MARECHAL, R., GAY, F., MONSAERT, E., HENDLISZ, A., et al. (2006). Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study. BRITISH JOURNAL OF CANCER, 94(4), 481–485.
Vancouver
1.
DEMOLS A, Peeters M, POLUS M, MARECHAL R, GAY F, MONSAERT E, et al. Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study. BRITISH JOURNAL OF CANCER. NATURE PUBLISHING GROUP; 2006;94(4):481–5.
MLA
DEMOLS, A, Marc Peeters, M POLUS, et al. “Gemcitabine and Oxaliplatin (GEMOX) in Gemcitabine Refractory Advanced Pancreatic Adenocarcinoma: a Phase II Study.” BRITISH JOURNAL OF CANCER 94.4 (2006): 481–485. Print.